Great presentation yesterday by Prof Trent Munro and he has then followed through today with a great result.
Microba is in pole position to develop a microbiome based therapeutic for patients receiving immune checkpoint inhibitor therapy across a range of cancers. Only 30% of cancer patients respond to cancer drugs but combined with a microbiome based therapeutic it can increase that response rate substantially.
I can see Microba partnering up quickly with big pharma.
A US$30 bil opportuniity for Microba with a greater than 15% CAGR.
- Forums
- ASX - By Stock
- MAP
- Ann: Positive first animal data for Cancer Program
Ann: Positive first animal data for Cancer Program, page-2
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MAP (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $78.37M |
Open | High | Low | Value | Volume |
17.0¢ | 17.5¢ | 17.0¢ | $2.196K | 12.78K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 90212 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 38095 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 90212 | 0.165 |
1 | 6000 | 0.160 |
1 | 90000 | 0.155 |
1 | 5000 | 0.150 |
2 | 11551 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 39670 | 2 |
0.180 | 104588 | 4 |
0.190 | 109864 | 4 |
0.195 | 102543 | 3 |
0.200 | 50000 | 1 |
Last trade - 14.14pm 23/07/2024 (20 minute delay) ? |
Featured News
MAP (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online